[Psychiatric use of a new tranquilizer: 2-methyl-2-N-propyl-1,3-propanediol dicarbamate (meprobamate)].
D006993:Hypnotics and Sedatives; D001523:Mental Disorders / Q000628:therapy*; D008620:Meprobamate / Q000627:therapeutic use*; D019946:Propylene Glycol; D011409:Propylene Glycols; D014149:Tranquilizing Agents
D006993:Hypnotics and Sedatives; D011409:Propylene Glycols; D014149:Tranquilizing Agents; C041787:1,3-propanediol; D019946:Propylene Glycol; D008620:Meprobamate
MENTAL DISORDERS/therapy; MEPROBAMATE/therapeutic use
L'impiego in terapia psichiatrica di un nuovo farmaco tranquillizzante: il dicarbamato di metil-propil-propandiolo (meprobamato).